USANA Health Sciences (USNA) Tops Q2 EPS by 16c; Reiterates Guidance
Tweet
Share
E-mailGet Alerts USNA Hot Sheet
Price: $19.20 --0%
EPS Growth %: -41.9%
Financial Fact:
Net sales: 254.22M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -41.9%
Financial Fact:
Net sales: 254.22M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
USANA Health Sciences (NYSE: USNA) reported Q2 EPS of $1.87, $0.16 better than the analyst estimate of $1.71. Revenue for the quarter came in at $336.8 million versus the consensus estimate of $332.61 million.
GUIDANCE:
Reiterates 2021 net sales and diluted EPS outlook.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Stifel Canada Starts BlackBerry (BB) at Buy
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
